Journal
International Journal of Molecular Sciences
Publication Date
12-19-2022
Volume
23
Issue
24
First Page
162313
Document Type
Open Access Publication
DOI
10.3390/ijms232416213
Rights and Permissions
Jurutka, P.W.; di Martino, O.; Reshi, S.; Mallick, S.; Sausedo, M.A.; Moen, G.A.; Lee, I.J.; Ivan, D.J.; Krall, T.D.; Peoples, S.J.; Perez, A.; Tromba, L.; Le, A.; Khadka, I.; Petros, R.; Savage, B.M.; Salama, E.; Salama, J.; Ziller, J.W.; Noh, Y.; Lee, M.-Y.; Liu, W.; Welch, J.S.; Marshall, P.A.; Wagner, C.E. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene. Int. J. Mol. Sci. 2022, 23, 16213. https://doi.org/10.3390/ijms232416213 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Jurutka, Peter W; di Martino, Orsola; and et al., "An isochroman analog of CD3254 and allyl-, isochroman-analogs of NEt-TMN prove to be more potent retinoid-X-receptor (RXR) selective agonists than bexarotene." International Journal of Molecular Sciences. 23, 24. 162313 (2022).
https://digitalcommons.wustl.edu/oa_4/1060
Additional Links
Supplemental material is available for this article at publisher site.
